ETON PHARMACEUTICALS INC (ETON)
US29772L1089 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 21.83M 54,475.00% | 21.25M -2.66% | 31.642M 48.90% | 38.681M 22.25% | 69.732M 80.27% | 99.344M 42.47% | 134.51M 35.40% | 171.18M 27.26% | 208.44M 21.77% | 243.16M 16.66% | 272.8M 12.19% | |
| EBITDA YoY % growth | -1.04M 96.07% | -6.98M -571.15% | -291K 95.83% | -1.53M -425.77% | 17.34M 1,233.33% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.5M 94.47% | -8.75M -483.33% | -1.192M 86.38% | -2.986M -150.46% | 13.972M 567.99% | 23.423M 67.64% | 41.052M 75.26% | 64.933M 58.17% | 92.773M 42.87% | 116.38M 25.45% | 134.42M 15.50% | |
| Operating Margin | -6.87% | -41.18% | -3.77% | -7.72% | 20.04% | 23.58% | 30.52% | 37.93% | 44.51% | 47.86% | 49.27% | |
| EPS YoY % growth | -0.11 91.91% | -0.35 -218.18% | -0.06 82.86% | -0.14 -129.50% | 0.43 411.11% | 0.83 92.86% | 1.28 54.32% | 1.61 26.40% | 2.30 42.41% | 2.88 25.33% | 3.33 15.60% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 77.33% | 0.05 253.00% | 0.06 151.00% | 0.14 359.00% | 0.18 1,000.00% |
| Revenue Q2Q % growth | 11.006M 50.50% | 14.331M 79.90% | 15.759M 73.67% | 18.819M 82.28% | 20.859M 89.52% |
| EBITDA Q2Q % growth | 959.82K 187.90% | 2.292M 518.25% | 2.498M 203.14% | 5.37M 313.08% | 7.198M 649.93% |
| EBIT Q2Q % growth | 320.28K 116.07% | 1.938M 342.25% | 2.142M 172.98% | 4.998M 881.93% | 6.936M 2,065.61% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.03 250.00% | -0.01 | 0.04 | 394.12% |
| Q2 2024 Q2Q % growth | -0.12 -180.00% | -0.07 | -0.05 | -68.07% |
| Q1 2024 Q2Q % growth | -0.03 70.00% | -0.05 | 0.02 | 34.64% |
| Q4 2023 Q2Q % growth | -0.09 -325.00% | -0.04 | -0.05 | -120.59% |
| Q3 2023 Q2Q % growth | -0.02 83.33% | -0.10 | 0.08 | 80.39% |
| Q2 2023 Q2Q % growth | 0.15 350.00% | -0.09 | 0.24 | 263.40% |
| Q1 2023 Q2Q % growth | -0.10 52.38% | -0.14 | 0.04 | 29.97% |
| Q4 2022 Q2Q % growth | 0.04 | 0.01 | 0.03 | 292.16% |
| Q3 2022 Q2Q % growth | -0.12 50.00% | -0.15 | 0.03 | 21.57% |
| Q2 2022 Q2Q % growth | -0.06 40.00% | 0.03 | -0.09 | -296.08% |
| Q1 2022 Q2Q % growth | -0.21 -210.53% | -0.08 | -0.13 | -157.35% |
| Q4 2021 Q2Q % growth | 0.04 112.50% | 0.19 | -0.15 | -79.36% |
| Q3 2021 Q2Q % growth | -0.24 22.58% | -0.14 | -0.10 | -74.29% |
| Q2 2021 Q2Q % growth | -0.10 56.52% | -0.14 | 0.04 | 29.97% |
| Q1 2021 Q2Q % growth | 0.19 138.00% | 0.19 | 0.00 | -1.96% |
| Q4 2020 Q2Q % growth | -0.32 -113.33% | -0.27 | -0.05 | -20.66% |
| Q3 2020 Q2Q % growth | -0.31 -10.71% | -0.26 | -0.05 | -19.97% |
| Q2 2020 Q2Q % growth | -0.23 -27.78% | -0.27 | 0.04 | 13.27% |
| Q1 2020 Q2Q % growth | -0.50 | -0.23 | -0.27 | -119.49% |
| Q4 2019 Q2Q % growth | -0.15 | -0.27 | 0.12 | 44.15% |
| Q3 2019 Q2Q % growth | -0.28 | -0.25 | -0.03 | -11.29% |
| Q2 2019 Q2Q % growth | -0.18 | -0.28 | 0.10 | 35.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 10.324M 46.90% | 9.889M | 435K | 4.40% |
| Q2 2024 Q2Q % growth | 9.074M -24.36% | 8.976M | 98K | 1.09% |
| Q1 2024 Q2Q % growth | 7.966M 50.19% | 8.16M | -194K | -2.38% |
| Q4 2023 Q2Q % growth | 7.313M -13.96% | 7.854M | -541K | -6.89% |
| Q3 2023 Q2Q % growth | 7.028M 118.26% | 6.384M | 644K | 10.09% |
| Q2 2023 Q2Q % growth | 11.997M 63.00% | 6.639M | 5.358M | 80.70% |
| Q1 2023 Q2Q % growth | 5.304M 143.30% | 4.647M | 657K | 14.14% |
| Q4 2022 Q2Q % growth | 8.5M 39.57% | 9.301M | -801K | -8.61% |
| Q3 2022 Q2Q % growth | 3.22M 312.82% | 3.11M | 110K | 3.54% |
| Q2 2022 Q2Q % growth | 7.36M 139.74% | 7.92M | -560K | -7.07% |
| Q1 2022 Q2Q % growth | 2.18M -81.68% | 7.242M | -5.062M | -69.90% |
| Q4 2021 Q2Q % growth | 6.09M 7,512.50% | 12.768M | -6.678M | -52.30% |
| Q3 2021 Q2Q % growth | 780K 587.50% | 3.102M | -2.322M | -74.85% |
| Q2 2021 Q2Q % growth | 3.07M 15,250.00% | 3.887M | -817K | -21.02% |
| Q1 2021 Q2Q % growth | 11.9M 11,800.00% | 12.295M | -395K | -3.21% |
| Q4 2020 Q2Q % growth | 80K -82.61% | 1.361M | -1.281M | -94.12% |
| Q3 2020 Q2Q % growth | -160K | 1.519M | -1.679M | -110.53% |
| Q2 2020 Q2Q % growth | 20K | 300.217K | -280.217K | -93.34% |
| Q1 2020 Q2Q % growth | 100K -80.00% | 1.545M | -1.445M | -93.53% |
| Q4 2019 Q2Q % growth | 460K | 683.737K | -223.737K | -32.72% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -200% | 22.86% | 10% |
| Revenue | 0% | -3.23% | 2.2% | 2.2% |